(1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione

C31H50O11 — CID 23259864

IUPAC(1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione
SMILESCC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@H]2OC(O)C[C@H]2C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC
InChIInChI=1S/C31H50O11/c1-8-24-21(15-39-31-30(38-7)29(37-6)27(36)19(5)40-31)11-16(2)9-10-22(32)17(3)12-20-13-25(34)42-28(20)18(4)23(33)14-26(35)41-24/h9-11,17-21,23-25,27-31,33-34,36H,8,12-15H2,1-7H3/b10-9+,16-11+/t17-,18+,19-,20-,21-,23-,24-,25?,27-,28-,29-,30-,31-/m1/s1
InChIKeyWSMKLTCWLZNTGC-VRHVQRJWSA-N
MW598.73 g/mol
LogP2.30
Rot. Bonds6

About (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione

(1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione (PubChem CID 23259864) has the molecular formula C31H50O11 and a molecular weight of 598.73 g/mol. Its IUPAC name is (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione.

Molecular Properties

Compound Name(1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione
PubChem CID23259864
Molecular FormulaC31H50O11
Molecular Weight598.73 g/mol
Exact Mass598.34
IUPAC Name(1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione
SMILESCC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@H]2OC(O)C[C@H]2C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC
InChIInChI=1S/C31H50O11/c1-8-24-21(15-39-31-30(38-7)29(37-6)27(36)19(5)40-31)11-16(2)9-10-22(32)17(3)12-20-13-25(34)42-28(20)18(4)23(33)14-26(35)41-24/h9-11,17-21,23-25,27-31,33-34,36H,8,12-15H2,1-7H3/b10-9+,16-11+/t17-,18+,19-,20-,21-,23-,24-,25?,27-,28-,29-,30-,31-/m1/s1
InChIKeyWSMKLTCWLZNTGC-VRHVQRJWSA-N
XLogP2.30
TPSA150.21 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500598.73
LogP ≤ 52.30
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Analyze (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione?
The IUPAC name of (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione (CID 23259864) is (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione.
What is the SMILES notation for (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione?
The canonical SMILES for (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione is CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@H]2OC(O)C[C@H]2C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC.
What is the InChIKey of (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione?
The InChIKey is WSMKLTCWLZNTGC-VRHVQRJWSA-N. The full InChI is InChI=1S/C31H50O11/c1-8-24-21(15-39-31-30(38-7)29(37-6)27(36)19(5)40-31)11-16(2)9-10-22(32)17(3)12-20-13-25(34)42-28(20)18(4)23(33)14-26(35)41-24/h9-11,17-21,23-25,27-31,33-34,36H,8,12-15H2,1-7H3/b10-9+,16-11+/t17-,18+,19-,20-,21-,23-,24-,25?,27-,28-,29-,30-,31-/m1/s1.
What are the key properties of (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione?
(1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione has a molecular weight of 598.73 g/mol, XLogP of 2.30, 6 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2S,3R,7R,8R,9E,11E,14R,16R)-7-ethyl-3,18-dihydroxy-8-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-2,10,14-trimethyl-6,19-dioxabicyclo[14.3.0]nonadeca-9,11-diene-5,13-dione is sourced from PubChem (CID 23259864), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).